Pharmacists Back Iowa Law Supporting Patient Access to Pharmacy Care



Alexandria, Va. Sept. 3, 2014 - National Community Pharmacists Association (NCPA) CEO B. Douglas Hoey, RPh, MBA, issued the following statement in response to announced litigation intended to thwart H.F. 2297, bipartisan legislation signed into law on March 14, 2014:

"NCPA has supported this bipartisan legislation all along because it is a common-sense solution and the right thing to do. For about a year now, the costs for scores of generic drugs have been skyrocketing by as much as 600%, 1,000% or more. The trend is well-documented by both an NCPA survey of more than 1,000 community pharmacists as well as by regional and national media outlets, including The New York Times and The Wall Street Journal.

"While the prices that pharmacies must pay their wholesalers for these medications continue to increase, insurance middlemen known as pharmacy benefit managers (PBMs) may wait months before they adjust reimbursement rates to reflect market costs, and rarely do so retroactively. This is forcing community pharmacies to 'buy high' and 'sell low' and routinely incur losses of $60, $100 or much more per prescription. That's unsustainable for any small business and is already reducing patient access to pharmacy care.

"Iowa is one of 16 states to enact legislation to address this problem—nearly one-third of the nation. Iowa's law should give the state's 300-plus independent community pharmacies some basic insights into their reimbursement from PBMs for common generic drugs, as well as set forth an appeals process to hopefully resolve differences that may emerge if PBMs continue to reimburse community pharmacies at lower, outdated rates.

"In addition federal Medicare officials have finalized a regulation for 2016 Medicare prescription drug plans that grants patients and community pharmacists some of the same protections included in H.F. 2297. Medicare took this action after considering and rejecting the same specious arguments that the PBMs are making now against the bipartisan Iowa law. In fact there is a track record of alarmist PBM claims of enormous cost increases that do not hold up to scrutiny.

"In opposing H.F. 2297, the trade group for PBMs is grossly distorting the law's provisions while trying to defend the indefensible—threatening patient access to medications by reimbursing pharmacies well below their cost of dispensing medications."

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U -
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii |
Pharmacy Interior | Image Credit: Tyler Olson -
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi -
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen |
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/ |
Image credit: fidaolga -
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund |
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi -
© 2023 MJH Life Sciences

All rights reserved.